Hangzhou Jiuyuan Gene Engineering

• A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy®

  Phase 3, Not yet recruiting, 370 people, 9 Oct 2024

• A Study of the Efficacy and Safety of Semaglutide Injection in the Treatment of Type 2 Diabetes Mellitus

  Phase 3, Completed, 476 people, 18 Apr 2023

Sources: clinicaltrials.gov